Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FN7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,249
Award facts
- Contract value 100% obligated
- $70,249.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $70,249.31 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The contract, issued on January 13, 2026, carries a completion date of January 14, 2026, and employs firm fixed-price pricing with no set-aside designation. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply deliveries supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies a comprehensive range of medications and medical commodities to federal agencies, including the Department of Defense and Department of Veterans Affairs. The company regularly fulfills competitive federal contracts for specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Dupixent, a specialty pharmaceutical used in the treatment of various inflammatory conditions, reflects the company's ongoing role as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3FN7?
SPE2DR26F3FN7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3FN7 worth?
The government has obligated $70,249 on SPE2DR26F3FN7.
Is contract SPE2DR26F3FN7 an order under another contract?
Yes. SPE2DR26F3FN7 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FN7 competed?
The extent of competition for SPE2DR26F3FN7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award